Current guidelines recommend screening kidney transplant candidates without known history of DM for abnormal glucose metabolism to enable early detection and management of related complications [13]
Pharmaceutical companies accept this is a possible side-effect of some GLP-1 medications for example it is mentioned in the patient leaflets of Wegovy but experts stress it is very rare
It is known that both T1DM and T2DM are characterized by increased ROS production, which correlates strongly with the development of diabetes and its associated complications [110, 111]
Consulte sempre um especialista para ajustes necessrios
Count: 10 Multiple Dose Vials Per Tray
Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FG, et al